GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VitaSpring Biomedical Co Ltd (OTCPK:VSBC) » Definitions » Other Net Income (Loss)

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Other Net Income (Loss) : $0.00 Mil (TTM As of Oct. 2022)


View and export this data going back to 2019. Start your Free Trial

What is VitaSpring Biomedical Co Other Net Income (Loss)?

VitaSpring Biomedical Co's Other Net Income (Loss) for the three months ended in Oct. 2022 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Oct. 2022 was $0.00 Mil.

VitaSpring Biomedical Co's quarterly Other Net Income (Loss) declined from Apr. 2022 ($0.00 Mil) to Jul. 2022 ($0.00 Mil) but then stayed the same from Jul. 2022 ($0.00 Mil) to Oct. 2022 ($0.00 Mil).


VitaSpring Biomedical Co Other Net Income (Loss) Historical Data

The historical data trend for VitaSpring Biomedical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VitaSpring Biomedical Co Other Net Income (Loss) Chart

VitaSpring Biomedical Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22
Other Net Income (Loss)
Get a 7-Day Free Trial - - - - -

VitaSpring Biomedical Co Quarterly Data
Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

VitaSpring Biomedical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VitaSpring Biomedical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


VitaSpring Biomedical Co (VitaSpring Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
400 Spectrum Center Dr. No. 1620, Irvine, CA, USA, 92618
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Headlines

No Headlines